Lucas Paglia
Advertisement
Lucas is a partner and associate in Kirkpatrick & Lockhart, www.kl.com, a national law firm experienced in complex commercial litigation, intellectual property enforcement, and regulatory practice
Articles by Lucas Paglia
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease
2
FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B
3
Pharmaceutical Executive Daily: Treasury Issues Notice to Add Biotech into Proposed COINS Act
4
Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program
5